CoChat

Low doses of caffeine reduce heart rate during submaximal cycle ergometry

Open access
McClaran, Steven R, Wetter, Thomas J · 2007 · Journal of the International Society of Sports Nutrition

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; 4 of the 61 sources its claims cite were checked for support.

Abstract

BACKGROUND: The purpose of this study was to examine the cardiovascular effects of two low-levels of caffeine ingestion in non habitual caffeine users at various submaximal and maximal exercise intensities. METHODS: Nine male subjects (19-25 yr; 83.3 +/- 3.1 kg; 184 +/- 2 cm), underwent three testing sessions administered in a randomized and double-blind fashion. During each session, subjects were provided 4 oz of water and a gelatin capsule containing a placebo, 1.5 mg/kg caffeine, or 3.0 mg/kg caffeine. After thirty minutes of rest, a warm-up (30 Watts for 2 min) the pedal rate of 60 rpm was maintained at a steady-state output of 60 watts for five minutes; increased to 120 watts for five minutes and to 180 watts for five minutes. After a 2 min rest the workload was 180 watts for one minute and increased by 30 watts every minute until exhaustion. Heart rate (HR) was measured during the last 15-seconds of each minute of submaximal exercise. Systolic blood pressure (BP) was measured at rest and during each of the three sub-maximal steady state power outputs. Minute ventilation (VE), Tidal volume (VT), Breathing frequency (Bf), Rating of perceived exertion (RPE), Respiratory exchange ratio (RER), and Oxygen consumption (VO2) were measured at rest and during each minute of exercise. RESULTS: Caffeine at 1.5 and 3.0 mg/kg body weight significantly lowered (p < 0.05) HR during all three submaximal exercise intensities compared to placebo (range - 4 to 7 bpm lower) but not at rest or maximal exercise. BP was significantly higher (p < 0.05) at rest and after the 3 mg/kg caffeine vs placebo (116 +/- 13 vs 123 +/- 10 mm Hg). Neither dose of caffeine had any effect on BP during submaximal exercise. Caffeine had no effect on VE, VT, VO2, RPE, maximal power output or time to exhaustion. CONCLUSION: In non habitual caffeine users it appears that consuming a caffeine pill (1.5 & 3.0 mg/kg) at a dose comparable to 1-3 cups of coffee lowers heart rate during submaximal exercise but not at near maximal and maximal exercise. In addition, this caffeine dose also only appears to affect systolic blood pressure at rest but not during cycling exercise.

Overview

CoChat Summary

TL;DR

In nine non-habitual caffeine-using male college students, low-dose caffeine (1.5 and 3.0 mg/kg) significantly reduced heart rate during submaximal cycle exercise by 4–7 bpm versus placebo, without affecting maximal exercise heart rate or performance. Resting systolic blood pressure was higher with 3.0 mg/kg caffeine, but caffeine had no blood pressure effect during submaximal exercise.

Key findings

  • Heart rate was significantly lower (p < 0.05) with both CAF1.5 and CAF3 versus placebo at all three submaximal intensities, with a range of 4 to 7 bpm lower; there were no differences between CAF1.5 and CAF3 during submaximal or maximal exercise.
  • Heart rate at rest tended to be lower after CAF3 versus placebo but was not statistically significant (p = 0.08); the lower heart rate effect was not present during the higher incremental test intensities or at maximal exercise.
  • Resting systolic blood pressure was significantly higher (p < 0.05) after CAF3 versus placebo (116 ± 13 mmHg vs 123 ± 10 mmHg), but neither caffeine dose affected blood pressure during submaximal exercise.
  • RER was significantly lower with CAF3 versus placebo at rest and at some exercise intensities; there were no significant differences in V_E, VO_2, V_T, RPE, peak workload, or time to exhaustion between trials. Bf was significantly lower (p < 0.05) at 45% VO_2max with CAF3 vs placebo.

Methods

  • Double-blind, randomized, placebo-controlled, within-subject design with nine male college subjects, age 19–25 yr, body weight 83.3 ± 9.3 kg, height 184 ± 6 cm, VO_2max 49.7 ± 6.3 ml/kg/min; all were normotensive, non-habitual caffeine users, aerobically active, healthy, and non-smokers.
  • Each subject completed three trials separated by at least 48 hours: placebo, 1.5 mg/kg caffeine (CAF1.5), or 3.0 mg/kg caffeine (CAF3). After 30 minutes of rest, subjects cycled at 60, 120, and 180 watts (~30%, ~46%, and ~64% VO_2max) for 5 minutes each, then completed an incremental test to exhaustion.
  • Heart rate, blood pressure, metabolic variables, and RPE were measured; data were analyzed with repeated-measures ANOVA, Mauchly’s Test of Sphericity, Greenhouse-Geisser correction when needed, and post hoc pairwise comparisons, with significance set at p ≤ 0.05.

Limitations

  • Stated: cardiac output was not measured, so the authors could only speculate that lower heart rate reflected increased or optimized stroke volume; they call for follow-up caffeine studies measuring stroke volume.
  • Stated: comparing the current results with previous studies is difficult because of different caffeine doses, exercise types and intensities, and varied use of habituated versus non-habituated subjects; the role of habituation remains unclear.
  • Evident: the sample was small (nine male college students), limiting generalizability; blood pressure was not measured during maximal exercise; and the study did not include women, older adults, or clinical populations.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/1550-2783-4-11

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Heart rate at rest and during exercise. Differences in heart rate between placebo and caffeine trials. Placebo, 1.5 and 3.0 represent dose of caffeine in mg·kg body weight-1. Values are listed as mean ± SE. * = the mean difference compared to placebo is significant (p < 0.05).
Figure 1 Heart rate at rest and during exercise. Differences in heart rate between placebo and caffeine trials. Placebo, 1.5 and 3.0 represent dose of caffeine in mg·kg body weight-1. Values are listed as mean ± SE. * = the mean difference compared to placebo is significant (p < 0.05).CC BY · PubMed Central
Figure 2 Systolic blood pressure at rest and during exercise. Differences in Systolic blood pressure between placebo and caffeine trials. Placebo, 1.5 and 3.0 represent dose of caffeine in mg·kg body weight-1. Values are listed as mean ± SE. * = the mean difference compared to placebo is significant (p < 0.05)
Figure 2 Systolic blood pressure at rest and during exercise. Differences in Systolic blood pressure between placebo and caffeine trials. Placebo, 1.5 and 3.0 represent dose of caffeine in mg·kg body weight-1. Values are listed as mean ± SE. * = the mean difference compared to placebo is significant (p < 0.05)CC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 3 Not valid · 14 Not checked · 28 Own results and interpretations

21 more claims

Create a free account to see all 47 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 16
  • Borderline: one of the tests for a substantial claim is unclear. 1
  • It may state two separate claims as one. 11

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 40 references

Research works printed but not linked: 6

  1. McNaughton L, 1987, Res Quarter, 58, 255
  2. Flinn S, 1990, Int J Sports Nutr, 11, 188
  3. French C, 1991, J Sports Med Phys Fitness, 31, 425
  4. Kaminsky LA, 1998, J Sports Med Phys Fitness, 38, 53
  5. Perkins R, 1975, Med Sci Sports, 7, 221
  6. Grollman A, 1930, J Pharmacol Exp Ther, 39, 313

Cited by

See all 46

Metadata

Authors
McClaran, S. R., & Wetter, T. J.
Affiliations
  • University of Wisconsin–Oshkosh (US)
  • University of Wisconsin–Stevens Point (US)
Corresponding author
McClaran, Steven R
Venue
Journal of the International Society of Sports Nutrition
Published
2007-07-13
Volume
4
Issue
1
Pages
11-11
ISSN
1550-2783 (ISSN-L)
OpenAlex
W2056941850
Cited by
46
References
40
Citations by year
2026: 2 · 2025: 1 · 2024: 4 · 2022: 3 · 2021: 2 · 2020: 4 · 2017: 5 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 4 · 2012: 3
FWCI
1.56
Type
journal article
Language
en
Open access
Locations
  • Journal of the International Society of Sports Nutrition (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Sports Performance and Training
Keywords
caffeine, heart rate, submaximal exercise, cycle ergometry, systolic blood pressure, exercise intensity, oxygen consumption, respiratory exchange ratio, rating of perceived exertion, caffeine dose-response, time to exhaustion, maximum power, endurance exercise performance, thermoregulation, thermoregulatory sweating

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low doses of caffeine reduce heart rate during submaximal cycle ergometry. https://app.cochat.ai/papers/10.1186/1550-2783-4-11
The paper
McClaran, S. R., & Wetter, T. J. (2007). Low doses of caffeine reduce heart rate during submaximal cycle ergometry. Journal of the International Society of Sports Nutrition. https://doi.org/10.1186/1550-2783-4-11

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.